myocardial T2*
Showing 1 - 25 of >10,000
Type 2 Diabetes, Myocardial Fibrosis, Myocardial Inflammation Trial in Seattle (dapagliflozin, Placebo)
Completed
- Type 2 Diabetes Mellitus
- +2 more
- dapagliflozin
- Placebo
-
Seattle, WashingtonUniversity of Washington
Jan 9, 2023
Microcirculatory Function in Type 2 Myocardial Infarction (T2MI)
Not yet recruiting
- Myocardial Infarction
- Coronary Microvascular Disease
- Coronary angiogram with coronary reactivity testing (CRT)
-
Rochester, MinnesotaMayo Clinic Rochester
Mar 30, 2023
Type II Myocardial Infarction Trial in Edmonton (Rivaroxaban 2.5 MG [Xarelto], Placebo)
Recruiting
- Type II Myocardial Infarction
- Rivaroxaban 2.5 MG [Xarelto]
- Placebo
-
Edmonton, Alberta, CanadaUniversity of Alberta
May 19, 2022
SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac
Recruiting
- Coronary Artery Disease
- Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
-
Shah Alam, Selangor, MalaysiaInstitute for Clinical Research, National Institutes of Health,
Nov 9, 2023
Breast Cancer, Myocardial Damage, Cardiotoxicity Trial in Dusseldorf (Cardiac MRI and echocardiography, laboratory parameters)
Completed
- Breast Cancer
- +2 more
- Cardiac MRI and echocardiography, laboratory parameters
-
Dusseldorf, GermanyDivision of Cardiology, Pulmonary Disease and Vascular Medicine
May 19, 2022
CMR in T2DM: The NSR Cohort
Enrolling by invitation
- Diabetes Mellitus, Type 2
- +4 more
- All subjects will undergo cardiac magnetic resonance imaging with gadolinium contrast and with adenosine myocardial perfusion
-
Slagelse, DenmarkSlagelse Hospital, department of cardiology and endocrinology, m
Jun 13, 2023
Type2 Diabetes Trial in Herlev (Empagliflozin, Placebo Oral Tablet)
Completed
- Type2 Diabetes Mellitus
- Empagliflozin
- Placebo Oral Tablet
-
Herlev, DenmarkHerlev og Gentofte Hospital
Aug 17, 2022
Preoperative BNP: Epidemiological Patterns, Management
Completed
- Myocardial Infarction Postoperative
- +2 more
- Cardiac risk stratification using preoperative BNP measurement, followed by postoperative cardiac monitoring
- Use of traditional perioperative cardiac risk stratification only
-
Edmonton, Alberta, CanadaUniversity of Alberta Hospital Pre-Admission Clinic
Jul 25, 2022
STEMI Trial in Edmonton (Intravenous N-Acetylcysteine)
Completed
- STEMI
- Intravenous N-Acetylcysteine
-
Edmonton, Alberta, CanadaUniversity of Alberta Hospital
Oct 3, 2022
Carotid Intraplaque Neovascularization Combined With Stress Echo
Recruiting
- Atherosclerosis
- +5 more
- Carotid Contrast Enhanced Ultrasound
-
Calgary, Alberta, Canada
- +3 more
Jun 8, 2022
Type 2 Diabetes, Diabetic Cardiomyopathies, HFpEF - Heart Failure With Preserved Ejection Fraction Trial in Oxford (IMB-1018972)
Recruiting
- Type 2 Diabetes
- +2 more
-
Oxford, United KingdomOxford University Hospital
Jan 9, 2023
Chronic Kidney Disease (CKD), Type 2 Diabetes (T2DM), Coronary Artery Disease (CAD) Trial in Jacksonville (Clopidogrel,
Active, not recruiting
- Chronic Kidney Disease (CKD)
- +2 more
- Clopidogrel
- Clopidogrel active metabolite
-
Jacksonville, FloridaUniversity of Florida Jacksonville
Aug 5, 2022
Acute Myocardial Infarction, Cardiogenic Shock Trial in Czechia, Slovakia (Cangrelor, Ticagrelor)
Recruiting
- Acute Myocardial Infarction
- Cardiogenic Shock
-
Prague, Please Select, Czechia
- +24 more
Oct 3, 2022
Stable Ischemic Heart Disease, Coronary Artery Disease, Beta-blocker Therapy Trial in Edmonton (Medical Assessment, Quality of
Recruiting
- Stable Ischemic Heart Disease
- +2 more
- Medical Assessment
- Quality of Life Assessment
-
Edmonton, Alberta, CanadaUniversity of Alberta Hospital
Jan 30, 2023
Coronary Artery Disease Trial in Toronto (Standard cardiac rehabilitation, Time-Restricted Eating)
Enrolling by invitation
- Coronary Artery Disease
- Standard cardiac rehabilitation
- Time-Restricted Eating
-
Toronto, Ontario, Canada
- +1 more
Jul 15, 2022
Myocardial Infarction Trial in Edmonton, Saskatoon (Early Access CR)
Suspended
- Myocardial Infarction
- Early Access CR
-
Edmonton, Alberta, Canada
- +1 more
Nov 4, 2021
Myocardial Infarction, STEMI Trial in Canada (SMART AMI APPLICATION)
Enrolling by invitation
- Myocardial Infarction
- STEMI
- SMART AMI APPLICATION
-
Brantford, Ontario, Canada
- +16 more
Mar 11, 2022
![](/image/sponsor/university_of_campania_"luigi_vanvitelli")
GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2
Recruiting
- Diabetes Mellitus, Type 2
- Myocardial Infarction
- PCI
-
Naples, ItalyCelestino Sardu
Aug 31, 2023
Myocardial Infarction, Coronary Artery Disease Trial in Glasgow (CT coronary angiography)
Recruiting
- Myocardial Infarction
- Coronary Artery Disease
- CT coronary angiography
-
Glasgow, United KingdomQueen Elizabeth University Hospital
Sep 26, 2023
Myocarditis, Heart Failure, Myocardial Fibrosis Trial in Bad Nauheim, Frankfurt, Mainz (Cardiac Imaging)
Active, not recruiting
- Myocarditis
- +3 more
- Cardiac Imaging
-
Bad Nauheim, Hessen, Germany
- +2 more
Dec 13, 2022
Cardiac Troponin Fragmentation After Heavy Physical Exercise The
Enrolling by invitation
- Myocardial Infarction
- Myocardial Injury
- Troponin fragmentation
-
Turku, FinlandUniversity of Turku
Aug 18, 2023
Myocardial Infarction Trial (primary percutaneous intervention)
Not yet recruiting
- Myocardial Infarction
- primary percutaneous intervention
- (no location specified)
Oct 25, 2022
Triggers of Acute Myocardial Infarction, Time of Onset of Acute Myocardial Infarction, Long-term Prognosis After Acute
Not yet recruiting
- Triggers of Acute Myocardial Infarction
- +2 more
-
Amman, JordanIstishari Hospital
Aug 7, 2023